Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.24p
   
  • Change Today:
      0.005p
  • 52 Week High: 0.88
  • 52 Week Low: 0.21
  • Currency: UK Pounds
  • Shares Issued: 3,970.31m
  • Volume: 16,978,121
  • Market Cap: £9.33m
  • RiskGrade: 429

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
Competitors: ValiRx, e-Therapeutics, Genflow Biosciences , Oxford Biodynamics

Key Personnel

CEO: Sara Barrington
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers
Non-Executive Dir: Lorenzo Gallon, Aubrey Powell

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.vericidx.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BM8HZD43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 0.24p
Change Today 0.005p
% Change 2.17 %
52 Week High 0.88
52 Week Low 0.21
Volume 16,978,121
Shares Issued 3,970.31m
Market Cap £9.33m
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.59% below the market average21.59% below the market average21.59% below the market average21.59% below the market average21.59% below the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
Price Trend
63.71% below the market average63.71% below the market average63.71% below the market average63.71% below the market average63.71% below the market average
62.79% below the sector average62.79% below the sector average62.79% below the sector average62.79% below the sector average62.79% below the sector average
Income Not Available
Growth
33.16% above the market average33.16% above the market average33.16% above the market average33.16% above the market average33.16% above the market average
35.71% above the sector average35.71% above the sector average35.71% above the sector average35.71% above the sector average35.71% above the sector average

Verici DX Dividends

No dividends found

Trades for 20-Oct-2026

Time Volume / Share Price
16:47 5,000,000 @ 0.23p
14:25 1,302,613 @ 0.23p
13:25 5,000,000 @ 0.23p
13:49 58,000 @ 0.23p
13:18 100,000 @ 0.23p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page